Korean Elderly Increasingly Hesitant to Get COVID Vaccine

It looks like South Korea is having the same problem many other countries are having with vaccine hesitancy:

People aged 75 and over wait for possible adverse reactions after receiving Pfizer shots at a Covid-19 vaccination center in Gwangju, South Jeolla, on Monday. The first round of Pfizer vaccinations resumed on May 22 after a temporary suspension due to a supply shortage. [YONHAP]
People aged 75 and over wait for possible adverse reactions after receiving Pfizer shots at a Covid-19 vaccination center in Gwangju, South Jeolla, on Monday. The first round of Pfizer vaccinations resumed on May 22 after a temporary suspension due to a supply shortage. [YONHAP]

Deaths following Pfizer jabs are exceeding those after AstraZeneca shots, although experts say that many of the casualties were over the age of 74, with weaker immune systems and pre-existing medical conditions.  

Since the vaccination program began on Feb. 26, a total of 153 cases of death after inoculation had been reported as of Monday, according to the Korea Disease Control and Prevention Agency (KDCA). Pfizer accounted for 93 cases and AstraZeneca 60.  (……….)  

Enthusiasm for the shots isn’t high. As of Monday, the booking rate for Covid-19 vaccinations — the percentage of people in an age group who have made reservations — was only 55.9 percent among people aged 60 to 74, who are eligible for the AstraZeneca vaccine. The booking rate for people between the ages of 60 to 64 was only 47.4 percent.  (……….)

Health authorities, however, explained that none of the deaths reported so far are related to the vaccinations.  

“On the elderly without underlying diseases who died after inoculation, we could find the causes of death through an autopsy, such as cardiac infarction, heart rupture or pulmonary embolism,” an official from the KDCA told the Korea JoongAng Daily.  

“We don’t think there is a meaningful difference [between AstraZeneca and Pfizer in terms of deaths] seeing the situations abroad,” the official added.  

The death rate per 100,000 vaccinated people was similar between Pfizer (2.71 per 100,000 people) and AstraZeneca (2.62 per 100,000 people), and those results were similar to other countries, according to the KDCA.  

For example, in the U.K. where a larger number of inoculations have being done, there were 3.19 deaths per 100,000 people for Pfizer, and 3.29 for AstraZeneca. 

Joong Ang Ilbo

You can read more at the link.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

3 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Korean Man
3 years ago

Further to the article, most of controversial news about the Astrazeneca vaccine are probably due to the poor quality control by the US vaccine manufacturer who made those vaccines.

https://www.nytimes.com/2021/04/23/us/astrazeneca-covid-vaccine-contamination.html

The Astrazeneca vaccines being used in South Korea are manufactured in South Korea, and they are safe to use.

Korean Man
3 years ago

Now that the country has enough vaccines, South Korea just vaccinated 650,000 people yesterday, and it’s shooting for one million per day vaccinations. The country’s shooting for 9 million people, everyone over the age of 65 to be vaccinated within the next two week period. Bad news for the 토착왜구’s who want to see the country fall on its face.

setnaffa
setnaffa
3 years ago

Alpo-zenaca has never been approved for use in the USA… and even Moon stopped using it. That’s why the RoK had a shortage.

But you be you. Are you sure you’re not a sockpuppet of that cravat dude?

3
0
Would love your thoughts, please comment.x
()
x